col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


353 Results       Page 1

 [1] 
European Respiratory Society : European Respiratory Journal
  original article Date Title Authors   All Authors
1 [GO] 2024―Jul―18 Murder, she wrote: a long story on long COVID is being written Joan B. Soriano, Julio Ancochea
2 [GO] 2024―Jul―11 Smoking and vaping alter genes related to mechanisms of SARS-CoV-2 susceptibility and severity Rachel Bowsher, Timothy H Marczylo, Karen Gooch, Alexis Bailey, Matthew D Wright, Emma L Marczylo
3 [GO] 2024―Apr―04 Symptoms before and after COVID-19: a population and case-control study using prospective data Carole H. Sudre, Michela Antonelli, Nathan J Cheetham, Erika Molteni, Liane S Canas, Vicky Bowyer, et al. (+11)
4 [GO] 2024―Apr―04 Dysfunctional breathing after COVID-19: recognition and ramifications Adam Gaffney
5 [GO] 2024―Mar―28 ERJPodcast March 2024: Long COVID
6 [GO] 2024―Mar―28 Lung MRI identifies potentially treatable subtypes of long COVID Alejandro P. Comellas, Sean B. Fain
7 [GO] 2024―Mar―07 A Proposed Approach to Pulmonary Long COVID: A Viewpoint Firoozeh V. Gerayeli, Rachel Eddy, Don D. Sin
8 [GO] 2024―Feb―29 “Age-related changes in plasma biomarkers and their association with mortality in COVID-19.” E.H.A. Michels, B. Appelman, J. de Brabander,et al.Eur Respir J2023; 62: 2300011.
9 [GO] 2024―Feb―22 Long-term Radiological and Pulmonary Function Abnormalities at 3-year post COVID-19 Hospitalization: A Longitudinal Cohort Study Xiaoyu Han, Lu Chen, Liyan Guo, Linxia Wu, Osamah Alwalid, Jie Liu, et al. (+17)
10 [GO] 2024―Feb―15 Core Outcome Measurement Set for Research and Clinical Practice in Post COVID-19 Condition (Long COVID) in Children and Young People: An International Delphi Consensus Study “PC-COS Children” Nina Seylanova, Anastasia Chernyavskaya, Natalia Degtyareva, Aigun Mursalova, Ali Ajam, Lin Xiao, et al. (+34)
11 [GO] 2024―Feb―08 Cluster Analysis to Identify Long COVID Phenotypes Using129Xe Magnetic Resonance Imaging: A Multi-centre Evaluation Rachel L Eddy, David Mummy, Shuo Zhang, Haoran Dai, Aryil Bechtel, Alexandra Schmidt, et al. (+9)
12 [GO] 2023―Nov―30 Long-term outcome of co-infection of COVID-19 and tuberculosis: the “cursed duet” Roland Diel, Neil W. Schluger
13 [GO] 2023―Oct―12 Impact of face masks on the 6-minute walk distance in pulmonary hypertension patients during the COVID-19 pandemic: a prospective, randomised cross-over study Max Wissmüller, Veit Wartner, Christopher Hohmann, Joana Adler, Tilmann Kramer, Martin Hellmich, et al. (+3)
14 [GO] 2023―Oct―12 Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort Nicolas Casco, Alberto Levi Jorge, Domingo Juan Palmero, Jan-Willem Alffenaar, Greg J. Fox, Wafaa Ezz, et al. (+170)
15 [GO] 2023―Sep―28 Differences in hospital admissions for acute exacerbations of COPD during the COVID-19 pandemic stratified by stable state blood eosinophil count Hnin Aung, Hamish McAuley, Kate Porter, Matthew Richardson, Adam Wright, Christopher E Brightling, Neil J Greening
16 [GO] 2023―Jul―07 Age, host response, and mortality in COVID-19 Viviane Cordeiro Veiga, Alexandre Biasi Cavalcanti
17 [GO] 2023―Jun―21 Air pollution and COVID-19 severity Jordi Sunyer, Payam Dadvand
18 [GO] 2023―Jun―21 Long-term exposure to air pollution and risk of SARS-CoV-2 infection and COVID-19 hospitalization or death: Danish nationwide cohort study Jiawei Zhang, Youn-Hee Lim, Rina So, Jeanette T. Jørgensen, Laust H. Mortensen, George M. Napolitano, et al. (+11)
19 [GO] 2023―Jun―21 Pre-admission ambient air pollution and blood soot particles predict hospitalisation outcomes in COVID-19 patients Stijn Vos, Elien De Waele, Pieter Goeminne, Esmée M. Bijnens, Eva Bongaerts, Dries S. Martens, et al. (+9)
20 [GO] 2023―Apr―27 Trends in COVID-19-associated mortality in patients with pulmonary hypertension: a COMPERA analysis Kai-Helge Schmidt, Katrin Milger, Christine Pausch, Doerte Huscher, David Pittrow, Ekkehard Grünig, et al. (+9)
21 [GO] 2023―Apr―20 Age-related changes in plasma biomarkers and their association with mortality in COVID-19 Erik H.A. Michels, Brent Appelman, Justin de Brabander, Rombout B.E. van Amstel, Osoul Chouchane, Christine C. A. van Linge, et al. (+9)
22 [GO] 2023―Apr―20 Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism Cindy M.M. de Jong, Chantal Visser, Remy H.H. Bemelmans, Wim G. Boersma, Bram van den Borst, J. Louise I. Burggraaf, et al. (+21)
23 [GO] 2023―Apr―04 New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic Anne C. Teirlinck, Caroline K. Johannesen, Eeva K. Broberg, Pasi Penttinen, Harry Campbell, Harish Nair, et al. (+33)
24 [GO] 2023―Apr―01 Panta rhei (Πάντα ῥεῖ), or everything flows with long COVID Joan B. Soriano, Jessica González, Antoni Torres
25 [GO] 2023―Mar―23 Cystic fibrosis transmembrane conductance regulator modulators attenuate platelet activation and aggregation in blood of healthy donors and COVID-19 patients Erik Asmus, Weronika Karle, Markus C. Brack, Corey Wittig, Felix Behrens, Leander Reinshagen, et al. (+24)
26 [GO] 2023―Mar―23 Long Covid: clues about causes Felicity Liew, Claudia Efstathiou, Peter JM Openshaw
27 [GO] 2023―Mar―16 Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID Nicholas A. Scott, Laurence Pearmain, Sean B. Knight, Oliver Brand, David J. Morgan, Christopher Jagger, et al. (+31)
28 [GO] 2023―Mar―06 A patient-tailored approach for corticosteroid treatment in COVID-19: still not there yet Mattia Nigro, James D. Chalmers, Stefano Aliberti
29 [GO] 2023―Mar―06 Oxysterol metabolism dictates macrophage influx during SARS-CoV-2 infection Thomas M Conlon, Ali Önder Yildirim
30 [GO] 2023―Feb―16 Preventing bronchiolitis among infants with non-pharmaceutical interventions outside pandemics: is it realistic? Eva S.L. Pedersen, Claudia E. Kuehni
31 [GO] 2023―Feb―09 “Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages.” K. Hönzke, B. Obermayer, C. Mache,et al.Eur Respir J2022; 60: 2102725
32 [GO] 2023―Jan―27 Pulmonary embolism in COVID-19 infection: a high case-fatality related to pulmonary embolism characteristics Francis Couturaud, Cécile Tromeur, Raphael Le Mao
33 [GO] 2023―Jan―27 Novel gas exchange analysis in COVID-19 lung disease Mike Hughes
34 [GO] 2023―Jan―20 Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study Frédéric Schlemmer, Simon Valentin, Laurent Boyer, Anne Guillaumot, François Chabot, Clairelyne Dupin, et al. (+39)
35 [GO] 2023―Jan―19 How do we enhance protective immunity to COVID-19 in lung transplant recipients? David W.J. Griffin, James H. McMahon
36 [GO] 2023―Jan―12 Reply to: Intrapulmonary Shunt and Alveolar Dead Space in a Cohort of Patients with Acute COVID-19 Pneumonitis and Early Recovery Maximilian Ackermann, Paul Tafforeau, Joseph Brunet, Jan C. Kamp, Christopher Werlein, Mark P. Kühnel, et al. (+5)
37 [GO] 2023―Jan―12 Is long COVID an autoimmune disease? Don D. Sin
38 [GO] 2022―Dec―22 Immunogenicity and safety of coadministration of COVID-19 and influenza vaccination Isabell Wagenhäuser, Julia Reusch, Alexander Gabel, Anna Höhn, Thiên-Trí Lâm, Giovanni Almanzar, et al. (+10)
39 [GO] 2022―Dec―14 Identification of two specific transcriptomic clusters of COVID-19 ARDS patients with different immune profiles and different outcomes Yuichiro Shindo, Charles S. Dela Cruz, Martin Witzenrath
40 [GO] 2022―Nov―17 GM-CSF targeting in COVID-19, an approach based on fragile foundations Katharina Kohler, Andrew Conway Morris
41 [GO] 2022―Nov―17 Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis Jordi Riera, Enric Barbeta, Adrián Tormos, Ricard Mellado-Artigas, Adrián Ceccato, Anna Motos, et al. (+64)
42 [GO] 2022―Nov―17 GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infection Cheng Xiang Foo, Stacey Bartlett, Keng Yih Chew, Minh Dao Ngo, Helle Bielefeldt-Ohmann, Buddhika Jayakody Arachchige, et al. (+16)
43 [GO] 2022―Nov―10 Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) Francesco Salton, Paola Confalonieri, Stefano Centanni, Michele Mondoni, Nicola Petrosillo, Paolo Bonfanti, et al. (+9)
44 [GO] 2022―Oct―20 Efficacy of 3 COVID-19 vaccine doses in lung transplant recipients: a multicentre cohort study Gaëlle Dauriat, Laurence Beaumont, Liem Binh Luong Nguyen, Benjamin Renaud Picard, Morgane Penhouet, Benjamin Coiffard, et al. (+10)
45 [GO] 2022―Oct―13 A Randomised trial of anti-GM-CSF Otilimab in severe COVID-19 pneumonia (OSCAR) Jatin Patel, Damon Bass, Albertus Beishuizen, Xavier Bocca Ruiz, Hatem Boughanmi, Anthony Cahn, et al. (+39)
46 [GO] 2022―Oct―13 Pulse oximeter measurement error of oxygen saturation in patients with SARS-CoV-2 infection stratified by smoking status Colin J Crooks, Joe West, Joanne R Morling, Mark Simmonds, Irene Juurlink, Steve Briggs, et al. (+5)
47 [GO] 2022―Oct―06 The COVID-19 pandemic and pulmonary arterial hypertension in Italy: adaptation, outcomes and valuable lessons learned Claudia Mickael, Michael H. Lee, Brian B. Graham
48 [GO] 2022―Sep―30 Impact of the COVID-19 pandemic on influenza and RSV antibody titres in the community - a prospective Cohort Study in Neustadt Thuringia/Germany Mathias W. Pletz, Ralf Dürrwald, Janine Reiche, Norman Rose, André Scherag, Sebastian Weis
49 [GO] 2022―Sep―22 Changes in cardiopulmonary exercise capacity and limitations 3 to 12 months after COVID-19 Charlotte Björk Ingul, Anne Edvardsen, Turid Follestad, Divna Trebinjac, Odd Andre Wathne Ankerstjerne, Eivind Brønstad, et al. (+8)
50 [GO] 2022―Sep―22 Short and Long Term Non-Invasive Cardiopulmonary Exercise Assessment in previously Hospitalized COVID-19 Patients Inderjit Singh, Phillip Joseph
51 [GO] 2022―Sep―22 Reply to: Effect of prone positioning without mechanical ventilation in COVID-19 patients with acute respiratory failure Orlando R. Pérez-Nieto, Eder I. Zamarron-Lopez, Josué L. Medina Estrada, Jesús Salvador Sánchez-Diaz, Manuel A. Guerrero-Gutiérrez, Diego Escarraman-Martinez, Raúl Soriano-Orozco
52 [GO] 2022―Sep―22 Effect of prone positioning without mechanical ventilation in COVID-19 patients with acute respiratory failure Yanfei Shen, Shangzhong Chen, Caibao Hu
53 [GO] 2022―Sep―22 Intrapulmonary Shunt and Alveolar Dead Space in a Cohort of Patients with Acute COVID-19 Pneumonitis and Early Recovery Piotr Harbut, G. Kim Prisk, Robert Lindwall, Sarah Hamzei, Jenny Palmgren, Catherine E. Farrow, et al. (+5)
54 [GO] 2022―Sep―22 Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms Kiho Son, Rameen Jamil, Abhiroop Chowdhury, Manan Mukherjee, Carmen Venegas, Kate Miyasaki, et al. (+22)
55 [GO] 2022―Sep―15 Transcriptomic clustering of critically ill COVID-19 patients Cecilia López-Martínez, Paula Martín-Vicente, Juan Gómez de Oña, Inés López-Alonso, Helena Gil-Peña, Elías Cuesta-Llavona, et al. (+13)
56 [GO] 2022―Aug―26 Does autonomous macrophage-driven inflammation promote alveolar damage in COVID-19? David H. Dockrell, Clark D. Russell, Brian McHugh, Rupsha Fraser
57 [GO] 2022―Aug―18 COVID-19 infection and its impact on case-fatality in patients with pulmonary embolism Lukas Hobohm, Ingo Sagoschen, Stefano Barco, Ioannis T. Farmakis, Ugo Fedeli, Sebastian Koelmel, et al. (+5)
58 [GO] 2022―Aug―10 “Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline.” James D. Chalmers, Megan L. Crichton, Pieter C. Goeminne, et al. Eur Respir J 2021; 57: 2100048.
59 [GO] 2022―Jul―28 COVID-19 drug research and the cohort multiple randomised controlled trial design Raphaël Porcher, Philippe Ravaud, Matthieu Resche-Rigon, Pierre Louis Tharaux, Xavier Mariette, Olivier Hermine
60 [GO] 2022―Jul―28 COVID-19 drug research and the cohort multiple randomised controlled trial design Rafael Dal-Ré
61 [GO] 2022―Jul―28 Air pollution, SARS-CoV-2 incidence and COVID-19 mortality in Rome - a longitudinal study Federica Nobile, Paola Michelozzi, Carla Ancona, Giovanna Cappai, Giulia Cesaroni, Marina Davoli, et al. (+8)
62 [GO] 2022―Jul―28 Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients Justin de Brabander, Erik Duijvelaar, Job R. Schippers, Patrick J. Smeele, Hessel Peters-Sengers, Jan Willem Duitman, et al. (+4)
63 [GO] 2022―Jul―28 Impact of COVID-19 social distancing measures on lung transplant recipients: decline in overall respiratory virus infections is associated with stabilisation of lung function Auke E.S. de Zwart, Annelies Riezebos-Brilman, Gerton A. Lunter, Ewald C.U. Neerken, Coretta C. van Leer-Buter, Jan-Willem C. Alffenaar, et al. (+6)
64 [GO] 2022―Jul―21 COVID-19 follow-up programs across Europe: an ERS END-COVID CRC survey Claudia Valenzuela, Mattia Nigro, James D. Chalmers, Scott Wagers, Aujayeb Avinash, Merel E. Hellemons, et al. (+3)
65 [GO] 2022―Jul―14 When should corticosteroids be used for COVID-19 infection? Charles Feldman, Grant Waterer
66 [GO] 2022―Jul―01 The association between immunosuppressant and the outcome of COVID-19 Chi-Kuei Hsu, Chih-Cheng Lai
67 [GO] 2022―Jul―01 Are intravenous corticosteroid pulses superior to low dose corticosteroids in patients with severe Covid-19? Viviane Cordeiro Veiga, Alexandre Biasi Cavalcanti
68 [GO] 2022―Jul―01 SARS-CoV-2-induced senescence as a potential therapeutic target Mary Denholm, Robert C. Rintoul, Daniel Muñoz-Espín
69 [GO] 2022―Jun―22 Airway immune responses to COVID-19 vaccination in COPD patients and healthy subjects Thomas Southworth, Natalie Jackson, Dave Singh
70 [GO] 2022―Jun―22 Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages Katja Hönzke, Benedikt Obermayer, Christin Mache, Diana Fathykova, Mirjana Kessler, Simon Dökel, et al. (+48)
71 [GO] 2022―Jun―16 Update March 2022: management of hospitalised adults with coronavirus disease-19 (COVID-19): a european respiratory society living guideline Nicolas Roche, Megan L Crichton, Pieter C Goeminne, Bin Cao, Marc Humbert, Michal Shteinberg, et al. (+13)
72 [GO] 2022―Jun―02 Strokes of a pen: seeing far beyond COVID-19 Massimiliano Polastri, Salvatore Campanello
73 [GO] 2022―May―26 Benefit of monoclonal antibodies in early treatment of COVID-19 after lung transplantation - a retrospective analysis in two centers Jens Gottlieb, Martin Kolditz, Nils Gade, Tobias Welte, Nikolaus Kneidinger
74 [GO] 2022―May―23 Genetic overlap between idiopathic pulmonary fibrosis and COVID-19 Richard J Allen, Beatriz Guillen-Guio, Emma Croot, Luke M Kraven, Samuel Moss, Iain Stewart, et al. (+2)
75 [GO] 2022―May―23 Cardiovascular outcomes in patients with chronic kidney disease and COVID-19: a multi-regional data-linkage study Emilie J. Lambourg, Peter J. Gallacher, Robert W. Hunter, Moneeza Siddiqui, Eve Miller-Hodges, James Chalmers, et al. (+3)
76 [GO] 2022―Apr―29 Identification of coronavirus particles by electron microscopy: a complementary tool for deciphering COVID-19 Sophia Havaki, Konstantinos Evangelou, Koralia Paschalaki, Russell Petty, Peter J Barnes, Vassilis G. Gorgoulis
77 [GO] 2022―Apr―29 Identification of coronavirus particles by electron microscopy requires demonstration of specific ultrastructural features Carsten Dittmayer, Michael Laue
78 [GO] 2022―Mar―31 Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia, A double-blind, randomised, placebo-controlled trial Carlo Salvarani, Marco Massari, Massimo Costantini, Domenico Franco Merlo, Gabriella Lucia Mariani, Pierluigi Viale, et al. (+39)
79 [GO] 2022―Mar―17 Clinical relevance of lung transplantation for COVID-19 ARDS: a nationwide study Christian Lang, Valentin Ritschl, Florian Augustin, Gyoergy Lang, Bernhard Moser, Shahrokh Taghavi, et al. (+23)
80 [GO] 2022―Mar―17 The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner? Roberto Badagliacca, Silvia Papa, Michele D'Alto, Stefano Ghio, Piergiuseppe Agostoni, Pietro Ameri, et al. (+28)
81 [GO] 2022―Mar―17 Clinical, radiological, and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection Claudia Ravaglia, Claudio Doglioni, Marco Chilosi, Sara Piciucchi, Alessandra Dubini, Giulio Rossi, et al. (+5)
82 [GO] 2022―Mar―02 Inspiratory Muscle Training Enhances Recovery Post COVID-19: A Randomised Controlled Trial Melitta A McNarry, Ronan M G Berg, James Shelley, Joanne Hudson, Zoe L Saynor, Jamie Duckers, et al. (+3)
83 [GO] 2022―Feb―15 Effects of COVID-19 protective face-masks and wearing durations onto respiratory-haemodynamic physiology and exhaled breath constituents Pritam Sukul, Julia Bartels, Patricia Fuchs, Phillip Trefz, Rasmus Remy, Leo Rührmund, et al. (+3)
84 [GO] 2022―Feb―10 Aspergillus tracheobronchitis in COVID-19 ARDS patients - a cohort study Philipp Koehler, Saskia von Stillfried, Jorge Garcia Borrega, Frieder Fuchs, Jon Salmanton-García, Fabian Pult, et al. (+7)
85 [GO] 2022―Feb―10 European Respiratory Society Statement on Long COVID-19 Follow-Up Katerina M Antoniou, Eirini Vasarmidi, Anne-Marie Russell, Claire Andrejak, Bruno Crestani, Marion Delcroix, et al. (+7)
86 [GO] 2022―Feb―10 Pneumomediastinum in COVID-19: a phenotype of severe COVID-19 pneumonitis? The results of the United Kingdom (POETIC) survey James Melhorn, Andrew Achaiah, Francesca M. Conway, Elizabeth M. F. Thompson, Erik W. Skyllberg, Joseph Durrant, et al. (+66)
87 [GO] 2022―Feb―10 Inhaled corticosteroids for outpatients with Covid-19: a meta-analysis Todd C. Lee, Émilie Bortolussi-Courval, Sara Belga, Nick Daneman, Adrienne K. Chan, Ryan Hanula, et al. (+2)
88 [GO] 2022―Feb―10 Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial Alvar Agustí, Gaston De Stefano, Alberto Levi, Xavier Muñoz, Christian Romero-Mesones, Oriol Sibila, et al. (+15)
89 [GO] 2022―Feb―10 Acute Exacerbation of Idiopathic Pulmonary Fibrosis after SARS-CoV-2 Vaccination Tomohiro Bando, Reoto Takei, Yoshikazu Mutoh, Hajime Sasano, Yasuhiko Yamano, Toshiki Yokoyama, et al. (+4)
90 [GO] 2022―Feb―03 Effect of Interleukin-6 Receptor Antagonists in Critically Ill Adult Patients with COVID-19 Pneumonia: two Randomised Controlled Trials of the CORIMUNO-19 Collaborative Group Olivier Hermine, Xavier Mariette, Raphael Porcher, Matthieu Resche-Rigon, Pierre-Louis Tharaux, Philippe Ravaud
91 [GO] 2022―Feb―03 Remote patient monitoring in COVID-19: a critical appraisal Henri Gruwez, Emma Bakelants, Pauline Dreesen, Jolien Broekmans, Maarten Criel, Michiel Thomeer, et al. (+2)
92 [GO] 2022―Feb―03 ECMO during the COVID19 pandemic: moving from rescue therapy to more reasonable indications Christian Karagiannidis, Thomas Bein, Tobias Welte
93 [GO] 2022―Jan―27 Pulse oximeters’ measurements vary across ethnic groups: An observational study in patients with Covid-19 infection Colin J Crooks, Joe West, Joanne R Morling, Mark Simmonds, Irene Juurlink, Steve Briggs, et al. (+5)
94 [GO] 2022―Jan―27 Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis Konstantinos Evangelou, Dimitris Veroutis, Koralia Paschalaki, Periklis G. Foukas, Nefeli Lagopati, Marios Dimitriou, et al. (+17)
95 [GO] 2022―Jan―20 Lung function during and after acute respiratory infection in COVID-19 positive and negative outpatients Pekka Tamminen, Dominik Kerimov, Hanna Viskari, Janne Aittoniemi, Jaana Syrjänen, Lauri Lehtimäki
96 [GO] 2021―Dec―16 Effect of high versus low dose of dexamethasone on clinical worsening in patients hospitalised with moderate or severe COVID-19 Pneumonia: an open-label, randomised clinical trial Manuel Taboada, Nuria Rodríguez, Pablo Manuel Varela, María Teresa Rodríguez, Romina Abelleira, Amara González, et al. (+18)
97 [GO] 2021―Dec―09 ORF8/ORF8a: a difference between SARS-CoV-2 and SARS-CoV Milad Zandi
98 [GO] 2021―Dec―02 Interstitial lung disease before and after COVID-19: a double threat? Claudia Valenzuela, Grant Waterer, Ganesh Raghu
99 [GO] 2021―Nov―25 Risk factors for mortality in patients with COVID-19 needing extracorporeal respiratory support Jordi Riera, Sara Alcántara, Camilo Bonilla, Phillip Fortuna, Aaron Blandino Ortiz, Ana Vaz, et al. (+31)
100 [GO] 2021―Nov―25 Higher frequency of comorbidities in fully vaccinated patients admitted to icu due to severe covid-19: a prospective, multicenter, observational study Anna Motos, Alexandre López-Gavín, Jordi Riera, Adrián Ceccato, Laia Fernández-Barat, Jesús F Bermejo-Martin, et al. (+17)
101 [GO] 2021―Nov―25 Dexamethasone in hospitalised coronavirus-19 patients not on intensive respiratory support Kristina Crothers, Rian DeFaccio, Janet Tate, Patrick R. Alba, Matthew Bidwell Goetz, Barbara Jones, et al. (+8)
102 [GO] 2021―Nov―25 Broadening symptom criteria improves early case identification in SARS-CoV-2 contacts Hamish Houston, Seran Hakki, Timesh D Pillay, Kieran Madon, Nieves Derqui-Fernandez, Aleksandra Koycheva, et al. (+19)
103 [GO] 2021―Nov―18 The paradox of immunosuppressants and COVID-19 Guang-Shing Cheng, Scott E. Evans
104 [GO] 2021―Nov―11 Tuberculosis and COVID-19 co-infection: description of the global cohort
105 [GO] 2021―Nov―04 Exercise capacity-impairment after COVID-19 pneumonia is mainly caused by deconditioning Kathleen Jahn, Mihaela Sava, Gregor Sommer, Desiree M. Schumann, Stefano Bassetti, Martin Siegemund, et al. (+5)
106 [GO] 2021―Oct―21 Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures Arutha Kulasinghe, Chin Wee Tan, Anna Flavia Ribeiro dos Santos Miggiolaro, James Monkman, Habib SadeghiRad, Dharmesh D. Bhuva, et al. (+15)
107 [GO] 2021―Oct―14 Prone positioning for non-intubated hypoxemic patients with COVID-19: cheap, easy, and makes sense, but does it work? Eric D. Morrell, Mark M. Wurfel
108 [GO] 2021―Oct―14 Saliva molecular testing for SARS-CoV-2: simplifying the diagnosis without losing accuracy Francesca Saluzzo, Paola Mantegani, Valeria Poletti de Chaurand, Federica Cugnata, Patrizia Rovere-Querini, Marta Cilla, et al. (+6)
109 [GO] 2021―Sep―24 Home-monitoring reduces hospital stay of COVID-19 patients Laura Agnes Grutters, Kalle Iskander Majoor, Eline Solange Kirsty Pol-Mattern, Johannes Anthonie Hardeman, Christiaan Franciscus Pieter van Swol, Adriane Dore Marie Vorselaars
110 [GO] 2021―Sep―16 Automated lung sound analysis using the LungPass platform: a sensitive and specific tool for identifying lower respiratory tract involvement in COVID-19 Elena A. Lapteva, Olga N. Kharevich, Victoria V. Khatsko, Natalia A. Voronova, Maksim V. Chamko, Irina V. Bezruchko, et al. (+9)
111 [GO] 2021―Sep―16 Convalescent plasma for SARS-CoV-2 infection: Win or Learn Enric Contreras-Barbeta, Anna Millan, Jordi Rello
112 [GO] 2021―Sep―16 Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for a tailored therapy Elena Ortona, Walter Malorni
113 [GO] 2021―Sep―02 Lifting dyspnoea invisibility: COVID-19 face masks, the experience of breathing discomfort, and improved lung health perception - a French nationwide survey Laure Serresse, Noémie Simon-Tillaux, Maxens Decavèle, Frederick Gay, Nathalie Nion, Sophie Lavault, et al. (+7)
114 [GO] 2021―Sep―02 The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection Daniel Ward, Sanne Gørtz, Martin Thomsen Ernst, Nynne Nyboe Andersen, Susanne K. Kjær, Jesper Hallas, et al. (+6)
115 [GO] 2021―Aug―26 Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study Giovanni Battista Migliori, Pei Min Thong, Jan-Willem Alffenaar, Justin Denholm, Marina Tadolini, Fatma Alyaquobi, et al. (+20)
116 [GO] 2021―Aug―26 Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma Timothy Devos, Quentin Van Thillo, Veerle Compernolle, Tomé Najdovski, Marta Romano, Nicolas Dauby, et al. (+20)
117 [GO] 2021―Aug―19 Predictors of severe COVID-19 in a registry-based Swedish cohort of patients with chronic obstructive pulmonary disease (COPD) Caroline Stridsman, Lowie E.G.W. Vanfleteren, Jon R. Konradsen, Sten Axelsson Fisk, Christophe Pedroletti, Yvonne Sjöö, et al. (+7)
118 [GO] 2021―Aug―12 Air pollution and COVID-19: clearing the air and charting a post-pandemic course: a joint workshop report of ERS, ISEE, HEI and WHO Zorana J. Andersen, Barbara Hoffmann, Lidia Morawska, Martin Adams, Eeva Furman, Arzu Yorgancioglu, et al. (+12)
119 [GO] 2021―Aug―12 Asthma and Coronavirus Disease 2019 Risk: a systematic review and meta-analysis Anthony P. Sunjaya, Sabine M. Allida, Gian Luca Di Tanna, Christine R. Jenkins
120 [GO] 2021―Aug―12 Hyperventilation as one of the mechanisms of persistent dyspnea in SARS-CoV-2 survivors Justina Motiejunaite, Pauline Balagny, Florence Arnoult, Laurence Mangin, Catherine Bancal, Emmanuelle Vidal-Petiot, et al. (+5)
121 [GO] 2021―Jul―29 Lessons learnt from hydroxychloroquine/azithromycin in treatment of COVID-19 Jiuyang Xu, Bin Cao
122 [GO] 2021―Jul―29 Smoking quantitatively increases risk for COVID-19 Fuquan Zhang, Ancha Baranova
123 [GO] 2021―Jul―22 Metabolomic analyses reveals new stage-specific features of the COVID-19 Hongling Jia, Chaowu Liu, Dantong Li, Qingsheng Huang, Dong Liu, Ying Zhang, et al. (+21)
124 [GO] 2021―Jul―22 Serotype transmission dynamics and reduced incidence of invasive pneumococcal disease caused by different serotypes after implementation of non-pharmaceutical interventions during COVID-19 pandemic Rajendra Prasad Janapatla, Chyi-Liang Chen, Anna Dudek, Hsin-Chieh Li, Hsin-Ping Yang, Lin-Hui Su, Cheng-Hsun Chiu
125 [GO] 2021―Jul―15 Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study Orlando R. Perez-Nieto, Diego Escarraman-Martinez, Manuel A. Guerrero-Gutierrez, Eder I. Zamarron-Lopez, Javier Mancilla-Galindo, Ashuin Kammar-García, et al. (+14)
126 [GO] 2021―Jul―08 Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights Peter AB Wark, Prabuddha S. Pathinayake, Mathew Suji Eapen, Sukhwinder Singh Sohal
127 [GO] 2021―Jul―08 Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial Leo Sekine, Beatriz Arns, Bruna R. Fabro, Murillo M. Cipolatt, Rafael R. G. Machado, Edison L. Durigon, et al. (+19)
128 [GO] 2021―Jul―08 Autoimmunity to Annexin A2 predicts mortality among hospitalised COVID-19 patients Marisol Zuniga, Claudia Gomes, Steven E. Carsons, Michael T. Bender, Paolo Cotzia, Qing Robert Miao, et al. (+2)
129 [GO] 2021―Jul―08 Phenotyping long COVID Robert Naeije, Sergio Caravita
130 [GO] 2021―Jul―01 A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19 Dave Singh, Maxim Bogus, Valentyn Moskalenko, Robert Lord, Edmund J. Moran, Glenn D. Crater, et al. (+10)
131 [GO] 2021―Jul―01 Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation Ingunn Skjørten, Odd Andre Wathne Ankerstjerne, Divna Trebinjac, Eivind Brønstad, Øystein Rasch-Halvorsen, Gunnar Einvik, et al. (+4)
132 [GO] 2021―Jul―01 Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study Ismail M Osmanov, Ekaterina Spiridonova, Polina Bobkova, Aysylu Gamirova, Anastasia Shikhaleva, Margarita Andreeva, et al. (+32)
133 [GO] 2021―Jun―25 Steroid use in elderly critically ill COVID-19 patients Christian Jung, Bernhard Wernly, Jesper Fjølner, Raphael Romano Bruno, David Dudzinski, Antonio Artigas, et al. (+22)
134 [GO] 2021―Jun―25 Prognostic factors for adverse outcomes in patients with COVID-19: a field-wide systematic review and meta-analysis Vanesa Bellou, Ioanna Tzoulaki, Maarten van Smeden, Karel G. M. Moons, Evangelos Evangelou, Lazaros Belbasis
135 [GO] 2021―Jun―25 The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort Rupert Waudby-West, Benjamin Parcell, Colin N A Palmer, Samira Bell, James D Chalmers, Moneeza K Siddiqui
136 [GO] 2021―Jun―17 Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2 specific T cells Catherine Riou, Georgia Schäfer, Elsa du Bruyn, Rene T. Goliath, Cari Stek, Huihui Mou, et al. (+3)
137 [GO] 2021―Jun―03 COVID-19 Pneumothorax in the United Kingdom: a prospective observational study using the ISARIC WHO clinical characterisation protocol Stefan J. Marciniak, James Farrell, Anthony Rostron, Ian Smith, Peter J. M. Openshaw, J. Kenneth Baillie, et al. (+2)
138 [GO] 2021―Jun―03 Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19-a randomised double-blinded placebo-controlled trial Pradeesh Sivapalan, Charlotte Suppli Ulrik, Therese Sophie Lapperre, Rasmus Dahlin Bojesen, Josefin Eklöf, Andrea Browatzki, et al. (+27)
139 [GO] 2021―May―20 Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study Guillaume Beltramo, Jonathan Cottenet, Anne-Sophie Mariet, Marjolaine Georges, Lionel Piroth, Pascale Tubert-Bitter, et al. (+2)
140 [GO] 2021―May―20 Increased detection of pulmonary tuberculosis amongst hospitalised inpatients during the COVID-19 pandemic Liang En Wee, Kenneth Choon Meng Goh, Edwin Philip Conceicao, Jamie Bee Xian Tan, Li-Hwei Sng, Indumathi Venkatachalam
141 [GO] 2021―May―13 Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission and role for pre-test probability scores and home treatment? Mitja Jevnikar, Olivier Sanchez, Marc Humbert, Florence Parent
142 [GO] 2021―May―06 Between inflammation and thrombosis - endothelial cells in COVID-19 Anna Birnhuber, Elisabeth Fliesser, Gregor Gorkiewicz, Martin Zacharias, Benjamin Seeliger, Sascha David, et al. (+5)
143 [GO] 2021―May―06 Multidisciplinary approach for post-acute COVID-19 syndrome: time to break down the walls David Montani, Laurent Savale, Antoine Beurnier, Romain Colle, Nicolas Noël, Tài Pham, et al. (+2)
144 [GO] 2021―Apr―29 Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors Rocco Francesco Rinaldo, Michele Mondoni, Elena Maria Parazzini, Federica Pitari, Elena Brambilla, Simone Luraschi, et al. (+6)
145 [GO] 2021―Apr―22 Interstitial lung disease increases susceptibility to and severity of COVID-19 Hyun Lee, Hayoung Choi, Bumhee Yang, Sun-Kyung Lee, Tai Sun Park, Dong Won Park, et al. (+5)
146 [GO] 2021―Apr―22 Thrombotic complications of vaccination against SARS-CoV-2: what pharmacovigilance reports tell us - and what they don't Stavros Konstantinides
147 [GO] 2021―Apr―16 COVID-19 pneumonia and the pulmonary vasculature - a marriage made in hell Peter M. George, Sujal R. Desai
148 [GO] 2021―Apr―16 Intrapulmonary bronchopulmonary anastomoses in COVID-19 respiratory failure Csaba Galambos, Douglas Bush, Steven H. Abman
149 [GO] 2021―Apr―16 Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase David M. Smadja, Qun-Ying Yue, Richard Chocron, Olivier Sanchez, Agnes Lillo-Le Louet
150 [GO] 2021―Apr―08 Prevalence of pulmonary embolism on hospital admission in COVID-19 patients: Is there a role for pre-test probability scores and home treatment? Angelo Porfidia, Enrico Pola, Roberto Pola
151 [GO] 2021―Apr―08 SARS-CoV-2 infections in people with PCD: neither frequent, nor particularly severe Eva S.L. Pedersen, Myrofora Goutaki, Amanda L. Harris, Lucy Dixon, Michele Manion, Bernhard Rindlisbacher, et al. (+2)
152 [GO] 2021―Apr―01 Home-monitoring reduced short stay admissions in suspected COVID-19 patients: COVID-box project Ebru Dirikgil, Rick Roos, Geert H. Groeneveld, Christian Heringhaus, Annemiek V. Silven, Annelieke H.J. Petrus, et al. (+8)
153 [GO] 2021―Apr―01 Inhaled corticosteroids downregulate SARS-CoV-2-related genes in COPD: results from a RCT Stephen Milne, Xuan Li, Chen Xi Yang, Fernando Sergio Leitao Filho, Ana I. Hernández Cordero, Cheng Wei Tony Yang, et al. (+5)
154 [GO] 2021―Mar―25 PaO2/FIO2 ratio: the mismeasure of oxygenation in COVID-19 Martin J. Tobin, Amal Jubran, Franco Laghi
155 [GO] 2021―Mar―25 The impact of asthma on mental health & wellbeing during COVID-19 lockdown Daniel H. Higbee, George W. Nava, Alex S.F. Kwong, James W. Dodd, Raquel Granell
156 [GO] 2021―Mar―25 Guideline directed management of COVID-19: Do's and Dont's Martin Kolb, Anh Tuan Dinh-Xuan, Laurent Brochard
157 [GO] 2021―Mar―11 Management of hospitalised adults with coronavirus disease-19 (COVID-19): A European Respiratory Society living guideline James D. Chalmers, Megan L. Crichton, Pieter C. Goeminne, Bin Cao, Marc Humbert, Michal Shteinberg, et al. (+13)
158 [GO] 2021―Mar―03 Reduction in asthma admissions during the COVID-19 pandemic: consequence of public health measures in Singapore Liang En Wee, Edwin Philip Conceicao, Jing Yuan Tan, Jean Xiang Ying Sim, Indumathi Venkatachalam
159 [GO] 2021―Feb―25 Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease Michael F. Morris, Yash Pershad, Paul Kang, Lauren Ridenour, Ben Lavon, Maarten Lanclus, et al. (+3)
160 [GO] 2021―Feb―18 Dynamics of SARS-CoV-2 shedding in the respiratory depends on the severity of disease in COVID-19 patients Dieter Munker, Andreas Osterman, Hans Stubbe, Maximilian Muenchhoff, Tobias Veit, Tobias Weinberger, et al. (+18)
161 [GO] 2021―Feb―18 Is high-dose glucocorticoid beneficial in COVID-19? Response to Correspondence Maryam Edalatifard, Maryam Akhtari, Mohammadreza Salehi, Elham Farhadi, Ahmadreza Jamshidi, Mahdi Mahmoudi, Abdolrahman Rostamian
162 [GO] 2021―Feb―11 Diffusion Capacity Abnormalities for Carbon Monoxide in Patients with COVID-19 At Three-Month Follow-up Wei Qin, Shi Chen, Yunxia Zhang, Fen Dong, Zhu Zhang, Bingzhu Hu, et al. (+12)
163 [GO] 2021―Feb―11 Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life Fabio Anastasio, Sarah Barbuto, Elisa Scarnecchia, Paolo Cosma, Alessandro Fugagnoli, Giulio Rossi, et al. (+2)
164 [GO] 2021―Feb―11 Chest x-ray or CT for COVID-19 pneumonia? Comparative study in a simulated triage setting Nicola Sverzellati, Christopher J Ryerson, Gianluca Milanese, Elisabetta A Renzoni, Annalisa Volpi, Paolo Spagnolo, et al. (+12)
165 [GO] 2021―Feb―11 Corticosteroids in Covid-19: One size does not fit all Athena Gogali, Chris Kyriakopoulos, Konstantinos Kostikas
166 [GO] 2021―Feb―11 Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with professional-collected nasal versus nasopharyngeal swab Andreas K. Lindner, Olga Nikolai, Chiara Rohardt, Susen Burock, Claudia Hülso, Alisa Bölke, et al. (+11)
167 [GO] 2021―Feb―11 Point-of-care lung ultrasound assessment for risk stratification and therapy guiding in COVID-19 patients. A prospective non-interventional study Jorge Rubio-Gracia, Ignacio Giménez-López, Vanesa Garcés-Horna, Daniel López-Delgado, Jose Luis Sierra-Monzón, Luis Martínez-Lostao, et al. (+9)
168 [GO] 2021―Feb―04 Genetic polymorphisms, vitamin D binding protein and vitamin D deficiency in COVID-19 Marijn M. Speeckaert, Reinhart Speeckeart, Joris R. Delanghe
169 [GO] 2021―Feb―04 Ethical obligations for supporting healthcare workers during the COVID-19 pandemic Alexander Supady, J. Randall Curtis, Crystal E. Brown, Daniel Duerschmied, Lyn Anne von Zepelin, Marc Moss, Daniel Brodie
170 [GO] 2021―Feb―03 Effect of Asthma and Asthma Medication on the Prognosis of Patients with COVID-19 Yong Jun Choi, Ju-Young Park, Hye Sun Lee, Jin Suh, Jeung Yoon Song, Min Kwang Byun, et al. (+5)
171 [GO] 2021―Jan―28 Is high-dose glucocorticoid beneficial in COVID-19? Valliappan Muthu, Inderpaul Singh Sehgal, Kuruswamy Thurai Prasad, Ritesh Agarwal
172 [GO] 2021―Jan―28 The evolution of the European Respiratory Journal: weathering the publishing pandemic Martin Kolb, James D. Chalmers, Marc Humbert
173 [GO] 2021―Jan―21 Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences Sheila K. Patel, Jennifer A. Juno, Wen Shi Lee, Kathleen M. Wragg, P. Mark Hogarth, Stephen J. Kent, Louise M. Burrell
174 [GO] 2021―Jan―21 Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection Frederik Trinkmann, Michael Müller, Alexandra Reif, Nicolas Kahn, Michael Kreuter, Franziska Trudzinski, et al. (+3)
175 [GO] 2021―Jan―20 Dyspnoea, lung function and CT findings three months after hospital admission for COVID-19 Tøri Vigeland Lerum, Trond Mogens Aaløkken, Eivind Brønstad, Bernt Aarli, Eirik Ikdahl, Kristine Marie Aarberg Lund, et al. (+8)
176 [GO] 2021―Jan―20 Intrapulmonary shunt measured by bedside pulse oximetry predicts worse outcomes in severe COVID-19 Aleksandra Kotwica, Harry Knights, Nikhil Mayor, Emma Russell-Jones, Theodore Dassios, David Russell-Jones
177 [GO] 2021―Jan―20 Cardiopulmonary recovery after COVID-19 - an observational prospective multi-center trial Thomas Sonnweber, Sabina Sahanic, Alex Pizzini, Anna Luger, Christoph Schwabl, Bettina Sonnweber, et al. (+43)
178 [GO] 2021―Jan―20 Vitamin D status and seroconversion for COVID-19 in UK healthcare workers Aduragbemi A Faniyi, Sebastian T Lugg, Sian E Faustini, Craig Webster, Joanne E Duffy, Martin Hewison, et al. (+4)
179 [GO] 2021―Jan―20 Complications of nasal and pharyngeal swabs - a relevant challenge of the COVID-19 pandemic? Bandik Föh, Max Borsche, Alexander Balck, Stefan Taube, Jan Rupp, Christine Klein, Alexander Katalinic
180 [GO] 2021―Jan―20 Noninvasive strategies in COVID-19: epistemology, randomised trials, guidelines, physiology Martin J. Tobin, Amal Jubran, Franco Laghi
181 [GO] 2021―Jan―20 Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with self-collected anterior nasal swab versus professional-collected nasopharyngeal swab Andreas K. Lindner, Olga Nikolai, Franka Kausch, Mia Wintel, Franziska Hommes, Maximilian Gertler, et al. (+12)
182 [GO] 2021―Jan―14 Increased focus on non-animal models for COVID-19 and non-COVID lung research Laura Gribaldo, Killian Hurley, Pieter Hiemstra, Catherine Greene
183 [GO] 2021―Jan―14 Collapse induration of alveoli is an ultrastructural finding in a COVID-19 patient Matthias Ochs, Sara Timm, Sefer Elezkurtaj, David Horst, Jenny Meinhardt, Frank L. Heppner, et al. (+3)
184 [GO] 2021―Jan―08 Pulmonary function and radiological features four months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study Sabina A. Guler, Lukas Ebner, Catherine Beigelman, Pierre-Olivier Bridevaux, Martin Brutsche, Christian Clarenbach, et al. (+12)
185 [GO] 2021―Jan―08 Proteinase release from activated neutrophils in mechanically ventilated patients with non-COVID-19 and COVID-19 pneumonia Seda Seren, Lohann Derian, Irem Keleş, Antoine Guillon, Adam Lesner, Loïc Gonzalez, et al. (+7)
186 [GO] 2021―Jan―04 Early use of nitazoxanide in mild Covid-19 disease: randomised, placebo-controlled trial Patricia R. M. Rocco, Pedro L. Silva, Fernanda F. Cruz, Marco Antonio C. M. Junior, Paulo F. G. M. M. Tierno, Marcos A. Moura, et al. (+23)
187 [GO] 2020―Dec―30 Pulmonary embolism in COVID-19: D-dimer threshold selection should not be based on maximising the Youden's index Daniël A. Korevaar, Josien van Es
188 [GO] 2020―Dec―30 Asthma and COVID-19: do we finally have answers? Katrien Eger, Elisabeth H. Bel
189 [GO] 2020―Dec―24 Cardiopulmonary Exercise Test might be Helpful For Insight Interpretation of Impaired Pulmonary Function on Recovered COVID-19 Patients Yi Gao, Ruchong Chen, Qian Geng, Xiaoneng Mo, Chen Zhan, Wenhua Jian, et al. (+2)
190 [GO] 2020―Dec―24 Pandemic trials: evidence-based medicine on steroids James D. Chalmers
191 [GO] 2020―Dec―22 Early COVID-19 Lockdown in Greece and IPF: A beneficial “impact” beyond any expectation Spyros A. Papiris, Demosthenes Bouros, Katerina Markopoulou, Lykourgos Kolilekas, Andriana I. Papaioannou, Vasilios Tzilas, et al. (+29)
192 [GO] 2020―Nov―19 Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia Susanna C. Larsson, Stephen Burgess, Dipender Gill
193 [GO] 2020―Nov―19 Sleep Laboratories Reopening and COVID-19: A European Perspective Sophia Schiza, Anita Simonds, Winfried Randerath, Francesco Fanfulla, Dries Testelmans, Ludger Grote, et al. (+5)
194 [GO] 2020―Nov―12 Impact of COVID-19 pandemic on tuberculosis laboratory services in Europe Vlad Nikolayevskyy, Yen Holicka, Dick van Soolingen, Marieke J. van der Werf, Csaba Ködmön, Elena Surkova, et al. (+3)
195 [GO] 2020―Nov―05 Why asthma might surprisingly protect against poor outcomes in COVID-19 Hugo Farne, Aran Singanayagam
196 [GO] 2020―Nov―05 Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure Laura Michalick, Sarah Weidenfeld, Benjamin Grimmer, Diana Fatykhova, Philip Daniel Solymosi, Felix Behrens, et al. (+17)
197 [GO] 2020―Nov―05 Impact of socio-economic status in patients hospitalised for COVID-19 in the Greater Paris area Lucile Sesé, Yann Nguyen, Etienne Giroux Leprieur, Isabella Annesi-Maesano, Catherine Cavalin, Jeanne Goupil de Bouillé, et al. (+9)
198 [GO] 2020―Nov―05 The Impact of COVID-19 on Patients with Asthma José Luis Izquierdo, Carlos Almonacid, Yolanda González, Carlos Del Rio-Bermúdez, Julio Ancochea, Remedios Cárdenas, Joan B Soriano
199 [GO] 2020―Nov―05 Caution in Interpretation of Abnormal Carbon Monoxide Diffusion Capacity in COVID-19 Patients David G. Chapman, Tanya Badal, Gregory G. King, Cindy Thamrin
200 [GO] 2020―Oct―22 COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry Shane Hanon, Guy Brusselle, Maud Deschampheleire, Renaud Louis, Alain Michils, Rudi Peché, et al. (+6)
201 [GO] 2020―Oct―22 A profile of a retrospective cohort of 22 patients of COVID-19 with active/treated tuberculosis Nitesh Gupta, Pranav Ish, Amitesh Gupta, Nipun Malhotra, Jose Antonio Caminero, Rupak Singla, et al. (+8)
202 [GO] 2020―Oct―15 mTORC1 hyperactivation in lymphangioleiomyomatosis leads to ACE2 upregulation in type II pneumocytes: implications for COVID-19 Yan Tang, David J. Kwiatkowski, Elizabeth P. Henske
203 [GO] 2020―Oct―15 Performance of prediction models for COVID-19: the Caudine Forks of the external validation Glen P. Martin, Matthew Sperrin, Giovanni Sotgiu
204 [GO] 2020―Oct―08 Continuous positive airway pressure in Covid-19 patients with moderate-to-severe respiratory failure Claudia Brusasco, Francesco Corradi, Antonia Di Domenico, Francesca Raggi, Graziano Timossi, Gregorio Santori, Vito Brusasco
205 [GO] 2020―Oct―02 Patient-reported outcome measures after COVID-19: a prospective cohort study Alyson W. Wong, Aditi S. Shah, James C. Johnston, Christopher Carlsten, Christopher J. Ryerson
206 [GO] 2020―Oct―02 Inflammation and Intussusceptive Angiogenesis in COVID-19: everything in and out of Flow Maximilian Ackermann, Steven J. Mentzer, Martin Kolb, Danny Jonigk
207 [GO] 2020―Oct―02 Covid-19: Opacification score is higher in the right lung and right lung involvement is a better predictor of ICU admission Deepak Nagra, Mark Russell, Mark Yates, James Galloway, Richard Barker, Sujal R. Desai, Sam Norton
208 [GO] 2020―Sep―29 Face masks, respiratory patients and COVID-19 Joan B Soriano, Antonio Anzueto, Sinthia Bosnic Anticevich, Alan Kaplan, Marc Miravitlles, Omar Usmani, et al. (+4)
209 [GO] 2020―Sep―25 The impact of COVID-19 and the restoration of tuberculosis services in the Western Pacific Region (revised) Chen-Yuan Chiang, Tauhid Islam, Caihong Xu, Thilaka Chinnayah, Anna Marie Celina Garfin, Kalpeshsinh Rahevar, Mario Raviglione
210 [GO] 2020―Sep―25 Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: An observational cohort study Rishi K. Gupta, Michael Marks, Thomas H. A. Samuels, Akish Luintel, Tommy Rampling, Humayra Chowdhury, et al. (+8)
211 [GO] 2020―Sep―24 “Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study.” Rong-Hui Du, Li-Rong Liang, Cheng-Qing Yang, Wen Wang, Tan-Ze Cao, Ming Li, Guang-Yun Guo, Juan Du, Chun-Lan Zheng, Qi Zhu, Ming Hu, Xu-Yan Li, Peng Peng and Huan-Zhong Shi. Eur Respir J 2020; 55: 2000524.
212 [GO] 2020―Sep―17 Response to: Factors limiting the utility of bronchoalveolar lavage in the diagnosis of COVID-19 Francesco Salton, Pietro Geri, Marco Confalonieri
213 [GO] 2020―Sep―17 Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial Maryam Edalatifard, Maryam Akhtari, Mohammadreza Salehi, Zohre Naderi, Ahmadreza Jamshidi, Shayan Mostafaei, et al. (+15)
214 [GO] 2020―Sep―17 In vivo demonstration of pulmonary microvascular involvement in COVID-19 using Dual-Energy Computed Tomography Salim Si-Mohamed, Nader Chebib, Monica Sigovan, Lea Zumbihl, Ségoléne Turquier, Sara Boccalini, et al. (+4)
215 [GO] 2020―Sep―17 Assessing self-medication for obstructive airway disease during COVID-19 using Google Trends Sabina Sahanic, Anna Boehm, Alex Pizzini, Thomas Sonnweber, Magdalena Aichner, Guenter Weiss, et al. (+2)
216 [GO] 2020―Sep―17 Pleural diseases and COVID-19: ubi fumus, ibi ignis José M. Porcel
217 [GO] 2020―Sep―10 COVID-19 and Pneumothorax: A Multicentre Retrospective Case Series Anthony W. Martinelli, Tejas Ingle, Joseph Newman, Iftikhar Nadeem, Karl Jackson, Nicholas D. Lane, et al. (+33)
218 [GO] 2020―Sep―10 Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients Basile Mouhat, Matthieu Besutti, Kevin Bouiller, Franck Grillet, Charles Monnin, Fiona Ecarnot, et al. (+11)
219 [GO] 2020―Sep―10 Reply to: Re: Predictors of mortality for patients with COVID-19 pneumonia caused by SARSCoV-2: a prospective cohort study Rong-Hui Du, Li-Rong Liang, Cheng-Qing Yang, Wen Wang, Tan-Ze Cao, Ming Li, et al. (+8)
220 [GO] 2020―Sep―10 How can we better predict pulmonary blood clots in patients hospitalised for COVID-19? Laurent Bertoletti, Menno V. Huisman
221 [GO] 2020―Sep―03 Confronting the controversy: Interleukin-6 and the COVID-19 cytokine storm syndrome Luke Y.C. Chen, Ryan L. Hoiland, Sophie Stukas, Cheryl L. Wellington, Mypinder S. Sekhon
222 [GO] 2020―Sep―03 Does Chemotherapy Reactivate SARS-CoV-2 in Cancer Patients Recovered from Prior COVID-19 Infection? Jianping Bi, Hong Ma, Dongsheng Zhang, Jing Huang, Dongqin Yang, Yajie Wang, et al. (+6)
223 [GO] 2020―Sep―03 Sarcoidosis in a time of pandemic Praveen Govender, Yvette C. Cozier
224 [GO] 2020―Aug―28 Factors limiting the utility of bronchoalveolar lavage in the diagnosis of Covid-19 Deepak Aggarwal, Varinder Saini
225 [GO] 2020―Aug―28 Highly sensitive and specific diagnosis of coronavirus disease 19 (COVID-19) by reverse transcription multiple cross displacement amplification-labelled nanoparticles biosensor Shijun Li, Weijia Jiang, Junfei Huang, Ying Liu, Lijuan Ren, Li Zhuang, et al. (+5)
226 [GO] 2020―Aug―28 Endothelial to mesenchymal transition (EndMT): a precursor to post-SARS-CoV-2 infection (COVID-19) interstitial pulmonary fibrosis and vascular obliteration? Mathew Suji Eapen, Wenying Lu, Archana Vijay Gaikwad, Prem Bhattarai, Collin Chia, Ashutosh Hardikar, et al. (+2)
227 [GO] 2020―Aug―28 High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU Tiphaine Guy, Audrey Créac'hcadec, Charles Ricordel, Alexandre Salé, Baptiste Arnouat, Jean-Louis Bizec, et al. (+6)
228 [GO] 2020―Aug―28 Author's Reply on High-Flow Nasal Cannula for COVID-19 Patients: Low Risk of Bio-Aerosol Dispersion Jie Li, James B. Fink, Stephan Ehrmann
229 [GO] 2020―Aug―28 Letter to the editor: “High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion” J. Elshof, R.H.J. Hebbink, M.L. Duiverman, R. Hagmeijer
230 [GO] 2020―Aug―28 Utility and safety of bronchoscopy during SARS-CoV-2 outbreak in Italy: a retrospective, multicenter study Michele Mondoni, Giuseppe Francesco Sferrazza Papa, Rocco Rinaldo, Paola Faverio, Almerico Marruchella, Francesca D'Arcangelo, et al. (+19)
231 [GO] 2020―Aug―28 Wnt5a and Wnt11 as acute respiratory distress syndrome biomarkers for SARS-CoV-2 patients Eun Young Choi, Hee Ho Park, Hyelim Kim, Hong Nam Kim, Inyoung Kim, Soyoung Jeon, et al. (+3)
232 [GO] 2020―Aug―19 Elevated ACE2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication Mengfei Chen, Wenjuan Shen, Nicholas R. Rowan, Heather Kulaga, Alexander Hillel, Murugappan Ramanathan, Andrew P. Lane
233 [GO] 2020―Aug―13 COVID-19 and COPD Janice M. Leung, Masahiro Niikura, Cheng Wei Tony Yang, Don D. Sin
234 [GO] 2020―Aug―13 COVID-19: Interim Guidance on Rehabilitation in the Hospital and Post-Hospital Phase from a European Respiratory Society and American Thoracic Society-coordinated International Task Force Martijn A. Spruit, Anne E. Holland, Sally J. Singh, Thomy Tonia, Kevin C. Wilson, Thierry Troosters
235 [GO] 2020―Aug―06 Limited role for bronchoalveolar lavage to exclude Covid-19 after negative upper respiratory tract swabs: a multicenter study Pietro Geri, Francesco Salton, Lina Zuccatosta, Mario Tamburrini, Marco Biolo, Annalisa Busca, et al. (+7)
236 [GO] 2020―Aug―06 Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived the hospitalisation Stefano Belli, Bruno Balbi, Ilaria Prince, Davide Cattaneo, Francesca Masocco, Sergio Zaccaria, et al. (+8)
237 [GO] 2020―Aug―06 SARS-CoV2 disrupts clinical research - the role of a rare disease-specific trial network Silke van Koningsbruggen-Rietschel, Fiona Dunlevy, Veerle Bulteel, Damian Downey, Lieven Dupont
238 [GO] 2020―Aug―03 Health care workers with COVID-19 in Mexico Silvio A. Ñamendys-Silva
239 [GO] 2020―Aug―03 Re: Predictors of mortality for patients with COVID-19 pneumonia caused by SARSCoV-2: a prospective cohort study Hai-Jun Yang, Yan-Mei Zhang, Min Yang, Xing Huang
240 [GO] 2020―Aug―03 Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicenter, cohort study Stefano Aliberti, Dejan Radovanovic, Filippo Billi, Giovanni Sotgiu, Matteo Costanzo, Tommaso Pilocane, et al. (+7)
241 [GO] 2020―Aug―03 Feasibility and clinical impact of out-of-ICU non-invasive respiratory support in patients with COVID-19 related pneumonia Cosimo Franco, Nicola Facciolongo, Roberto Tonelli, Roberto Dongilli, Andrea Vianello, Lara Pisani, et al. (+15)
242 [GO] 2020―Aug―03 Pathogenesis of COVID-19-induced ARDS: implications for an aging population Manuel A. Torres Acosta, Benjamin D. Singer
243 [GO] 2020―Aug―03 Pandemic Treatments on Trial: The bigger picture T. Kotsimbos, M. Humbert
244 [GO] 2020―Jul―30 Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases Theodoros V. Giannouchos, Roberto A Sussman, José M Mier, Konstantinos Poulas, Konstantinos Farsalinos
245 [GO] 2020―Jul―30 Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation Antoine Beurnier, Etienne-Marie Jutant, Mitja Jevnikar, Athénaïs Boucly, Jérémie Pichon, Mariana Preda, et al. (+17)
246 [GO] 2020―Jul―30 Cyclosporine: an old weapon in the fight against Coronaviruses Adam Molyvdas, Sadis Matalon
247 [GO] 2020―Jul―23 Confronting and mitigating the risk of COVID-19 Associated Pulmonary Aspergillosis (CAPA) Darius Armstrong-James, Jonathan Youngs, Tihana Bicanic, Alireza Abdolrasouli, David W. Denning, Elizabeth Johnson, et al. (+10)
248 [GO] 2020―Jul―23 Insight into impact of COVID-19 epidemic on tuberculosis burden in China Hongguang Chen, Konglai Zhang
249 [GO] 2020―Jul―23 Abnormal carbon monoxide diffusion capacity in COVID-19 patients at time of hospital discharge Samir Nusair
250 [GO] 2020―Jul―23 COVID-19 prediction models should adhere to methodological and reporting standards Gary S. Collins, Maarten van Smeden, Richard D. Riley
251 [GO] 2020―Jul―23 Impact of the SARS Coronavirus 2 epidemic on tuberculosis treatment outcome, Northern Italy Paola Magro, Beatrice Formenti, Valentina Marchese, Maurizio Gulletta, Lina Rachele Tomasoni, Silvio Caligaris, et al. (+2)
252 [GO] 2020―Jul―16 COVID-19 conundrum: Clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Robin Cherian, Bharatendu Chandra, Moon Ley Tung, Alain Vuylsteke
253 [GO] 2020―Jul―16 Clinical Application of Intelligent Oropharyngeal-swab Robot: Implication for COVID-19 Pandemic Shao-Qiang Li, Wen-Liang Guo, Hao Liu, Tao Wang, Yuan-Yuan Zhou, Tao Yu, et al. (+5)
254 [GO] 2020―Jul―16 Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study Guohui Fan, Chao Tu, Fei Zhou, Zhibo Liu, Yeming Wang, Bin Song, et al. (+10)
255 [GO] 2020―Jul―16 Awake Prone Positioning for Non-intubated Oxygen Dependent COVID-19 Pneumonia Patients Ziqin Ng, Woo Chiao Tay, Choon Heng Benjamin Ho
256 [GO] 2020―Jul―16 Added value of chest CT in suspected COVID-19: an analysis of 239 patients Daniël A. Korevaar, Ruud S. Kootte, Loek P. Smits, Joost G. van den Aardweg, Peter I. Bonta, Janke Schinkel, et al. (+7)
257 [GO] 2020―Jul―16 COVID-19: Guidance on Palliative care from a European Respiratory Society International Task Force Daisy J. A. Janssen, Magnus Ekström, David C. Currow, Miriam J. Johnson, Mathew Maddocks, Anita K. Simonds, et al. (+2)
258 [GO] 2020―Jul―16 Socioeconomic correlates of the SARS-CoV 2 and Influenza H1N1 outbreaks Jan Christian Kaiser, Georgios T. Stathopoulos
259 [GO] 2020―Jul―16 Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects Merel Jacobs, Hannelore P. Van Eeckhoutte, Sara R. A. Wijnant, Wim Janssens, Guy F. Joos, Guy G. Brusselle, Ken R. Bracke
260 [GO] 2020―Jul―16 Characteristics and Outcomes of Health and Social Care workers testing positive for SARS-CoV-2 in the Tayside region of Scotland Moneeza K. Siddiqui, Benjamin Parcell, Sarah Allstaff, Colin Palmer, James Chalmers, Samira Bell
261 [GO] 2020―Jul―16 The value of serology testing to manage SARS-CoV-2 infections Laia Fernández-Barat, Ruben López-Aladid, Antoni Torres
262 [GO] 2020―Jul―16 Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue Jennifer A. Aguiar, Benjamin J-M. Tremblay, Michael J. Mansfield, Owen Woody, Briallen Lobb, Arinjay Banerjee, et al. (+18)
263 [GO] 2020―Jul―06 Rapid onset honeycombing fibrosis in spontaneously breathing patient with Covid-19 Margot Combet, Arthur Pavot, Laurent Savale, Marc Humbert, Xavier Monnet
264 [GO] 2020―Jul―06 Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care? Margherita Giannini, Mickael Ohana, Benoit Nespola, Giovanni Zanframundo, Bernard Geny, Alain Meyer
265 [GO] 2020―Jul―06 Rationale and significance of patient selection in awake prone positioning for COVID-19 pneumonia Ching Feng Huang, Ya Fang Zhuang, Jiaxuan Liu, Chee Kiang Tay, Duu Wen Sewa
266 [GO] 2020―Jul―06 A Re-analysis in Exploring the Association between Temperature and COVID-19 Transmissibility: An Ecological Study with 154 Chinese Cities Jinjun Ran, Shi Zhao, Lefei Han, Gengze Liao, Kai Wang, Maggie H. Wang, Daihai He
267 [GO] 2020―Jul―06 JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk Puja Mehta, Coziana Ciurtin, Marie Scully, Marcel Levi, Rachel C. Chambers
268 [GO] 2020―Jul―06 Social stigma in the time of Coronavirus Giovanni Sotgiu, Claudia C. Dobler
269 [GO] 2020―Jul―02 Potential of regulatory T cell-based therapies in the management of severe COVID-19 Emmanuel Stephen-Victor, Mrinmoy Das, Anupama Karnam, Bruno Pitard, Jean-François Gautier, Jagadeesh Bayry
270 [GO] 2020―Jul―02 Using imaging to combat a pandemic: rationale for developing the UK National COVID-19 Chest Imaging Database Joseph Jacob, Daniel Alexander, J. Kenneth Baillie, Rosalind Berka, Ottavia Bertolli, James Blackwood, et al. (+25)
271 [GO] 2020―Jul―02 Challenges of evaluating lung function as part of cancer care during the COVID-19 pandemic Justin L. Garner, Pallav L. Shah
272 [GO] 2020―Jul―02 Development of a Clinical Decision Support System for Severity Risk Prediction and Triage of COVID-19 Patients at Hospital Admission: an International Multicenter Study Guangyao Wu, Pei Yang, Yuanliang Xie, Henry C. Woodruff, Xiangang Rao, Julien Guiot, et al. (+23)
273 [GO] 2020―Jul―02 COVID-19 phenotypes: leading or misleading? Luciano Gattinoni, Luigi Camporota, John J. Marini
274 [GO] 2020―Jul―02 Remote Monitoring of Oxygen Saturation in Individuals with COVID-19 Pneumonia Orla O'Carroll, Rachel MacCann, Aoife O'Reilly, Eleanor M. Dunican, Eoin R. Feeney, Silke Ryan, et al. (+5)
275 [GO] 2020―Jul―02 Cyclophilin Inhibitors Restrict Middle East Respiratory Syndrome Coronavirus Via Interferon λ In Vitro And In Mice Lucie Sauerhering, Alexandra Kupke, Lars Meier, Erik Dietzel, Judith Hoppe, Achim D. Gruber, et al. (+11)
276 [GO] 2020―Jun―25 COVID-19 and pulmonary rehabilitation: preparing for phase three Massimiliano Polastri, Stefano Nava, Enrico Clini, Michele Vitacca, Rik Gosselink
277 [GO] 2020―Jun―25 On Tuberculosis and COVID-19 co-infection Marina Tadolini, José-María García-García, François-Xavier Blanc, Sergey Borisov, Delia Goletti, Ilaria Motta, et al. (+4)
278 [GO] 2020―Jun―25 COVID-19 from the land “Down Under” in an upside-down world: an Australian perspective Catherine Rang, Allen Cheng, Paul Kelly, Tom Kotsimbos
279 [GO] 2020―Jun―25 Go slow to go fast: A plea for sustained scientific rigor in air pollution research during the COVID-19 pandemic Dick J.J. Heederik, Lidwien A.M. Smit, Roel C.H. Vermeulen
280 [GO] 2020―Jun―25 A Global Respiratory Perspective on the COVID-19 Pandemic: Commentary and Action Proposals Teresa To, Giovanni Viegi, Alvaro Cruz, Luis Taborda-Barata, Monica Asher, Digambar Behera, et al. (+24)
281 [GO] 2020―Jun―25 Impaired pulmonary function in discharged patients with COVID-19: More work ahead Ruchong Chen, Yi Gao, Mu Chen, Wenhua Jian, Chunliang Lei, Jinping Zheng, Shiyue Li
282 [GO] 2020―Jun―25 Epidemic and pandemic viral infections: impact on tuberculosis and the lung. A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN) and members# of ESCMID Study Group for Mycobacterial Infections (ESGMYC) Catherine Wei Min Ong, Giovanni Battista Migliori, Mario Raviglione, Gavin MacGregor-Skinner, Giovanni Sotgiu, Jan-Willem Alffenaar, et al. (+41)
283 [GO] 2020―Jun―18 Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Alice Huertas, David Montani, Laurent Savale, Jérémie Pichon, Ly Tu, Florence Parent, et al. (+2)
284 [GO] 2020―Jun―18 The (in)significance of TB and COVID-19 co-infection Alkesh Kumar Khurana, Deepak Aggarwal
285 [GO] 2020―Jun―18 Thrombosis and COVID-19 pneumonia: the clot thickens! Laura C Price, Colm McCabe, Ben Garfield, Stephen J Wort
286 [GO] 2020―Jun―18 Potential role of memantine in the prevention and treatment of COVID-19: its antagonism of nicotinic acetylcholine receptors (nAChR) and beyond Senad Hasanagic, Fadila Serdarevic
287 [GO] 2020―Jun―18 Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post infection Justine Frija-Masson, Marie-Pierre Debray, Marie Gilbert, François-Xavier Lescure, Florence Travert, Raphaël Borie, et al. (+4)
288 [GO] 2020―Jun―11 Does bronchoscopy help the diagnosis in Covid-19 infection? Josuel Ora, Ermanno Puxeddu, Francesco Cavalli, Federica Maria Giorgino, Andrea Girolami, Marcello Chiocchi, et al. (+3)
289 [GO] 2020―Jun―08 The potential impact of COVID-19-related disruption on tuberculosis burden C. Finn McQuaid, Nicky McCreesh, Jonathan M. Read, Tom Sumner, Rein M. G. J. Houben, Richard G. White, Rebecca C. Harris
290 [GO] 2020―Jun―08 Tuberculosis in the time of COVID-19: quality of life and digital innovation Dina Visca, Simon Tiberi, Emanuele Pontali, Antonio Spanevello, Giovanni Battista Migliori
291 [GO] 2020―Jun―01 Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital Claudia Stochino, Simone Villa, Patrizia Zucchi, Pierpaolo Parravicini, Andrea Gori, Mario Carlo Raviglione
292 [GO] 2020―Jun―01 Estimates of the ongoing need for social distancing and control measures post-“lockdown” from trajectories of COVID-19 cases and mortality Mike Lonergan, James D. Chalmers
293 [GO] 2020―May―29 Children coronavirus dilemma Fabio Midulla, Luca Cristiani, Enrica Mancino
294 [GO] 2020―May―29 Responding to SARS-CoV-2 in South Africa: What can we learn from drug-resistant tuberculosis? Norbert Ndjeka, Francesca Conradie, Graeme Meintjes, Anja Reuter, Jennifer Hughes, Xavier Padanilam, et al. (+8)
295 [GO] 2020―May―26 Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases Marina Tadolini, Luigi Ruffo Codecasa, José-María García-García, François-Xavier Blanc, Sergey Borisov, Jan-Willem Alffenaar, et al. (+40)
296 [GO] 2020―May―26 Awake prone positioning for non-intubated oxygen dependent COVID-19 pneumonia patients Ziqin Ng, Woo Chiao Tay, Choon Heng Benjamin Ho
297 [GO] 2020―May―22 COVID-19 and the nicotinic cholinergic system Konstantinos Farsalinos, Athina Angelopoulou, Nikos Alexandris, Konstantinos Poulas
298 [GO] 2020―May―22 A Fully Automatic Deep Learning System for COVID-19 Diagnostic and Prognostic Analysis Shuo Wang, Yunfei Zha, Weimin Li, Qingxia Wu, Xiaohu Li, Meng Niu, et al. (+10)
299 [GO] 2020―May―22 COVID-19 in Italy - Passing through bitter waters Lorenzo Guglielmetti, Sheila Chiesi
300 [GO] 2020―May―22 COVID-19, tuberculosis, and poverty: preventing a perfect storm Matthew J. Saunders, Carlton A. Evans
301 [GO] 2020―May―19 COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection? Kielan Darcy McAlinden, Mathew Suji Eapen, Wenying Lu, Collin Chia, Greg Haug, Sukhwinder Singh Sohal
302 [GO] 2020―May―19 Impact of COVID-19 lockdown on adherence to continuous positive airway pressure (CPAP) by obstructive sleep apnoea patients David Attias, Jean Louis Pepin, Atul Pathak
303 [GO] 2020―May―19 The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients Marco Vicenzi, Roberta Di Cosola, Massimiliano Ruscica, Angelo Ratti, Irene Rota, Federica Rota, et al. (+3)
304 [GO] 2020―May―19 Smoking, ACE-2, and COVID-19: Ongoing Controversies Janice M. Leung, Don D. Sin
305 [GO] 2020―May―19 Authors’ reply to correspondence in response to “Will children reveal their secret? The coronavirus dilemma” F. Midulla, L. Cristiani, E. Mancino
306 [GO] 2020―May―19 Correspondence regarding recently published editorial: ‘Will children reveal their secret? The coronavirus dilemma’ Stefan Ebmeier, Aubrey J. Cunnington
307 [GO] 2020―May―19 Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection Dan Yan, Xiao-Yan Liu, Ya-nan Zhu, Li Huang, Bi-tang Dan, Guo-jun Zhang, Yong-hua Gao
308 [GO] 2020―May―19 Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset Bin Lou, Ting-Dong Li, Shu-Fa Zheng, Ying-Ying Su, Zhi-Yong Li, Wei Liu, et al. (+18)
309 [GO] 2020―May―19 Continuous positive airway pressure to avoid intubation in SARS-CoV-2 pneumonia: a two-period retrospective case-control study Mathilde Oranger, Jésus Gonzalez-Bermejo, Philippine Dacosta-Noble, Claudia Llontop, Antoine Guerder, Valery Trosini-Desert, et al. (+6)
310 [GO] 2020―May―12 Arterial hypertension and the risk of severity and mortality of COVID-19 C. E. Leiva Sisnieguez, W. G. Espeche, M. R. Salazar
311 [GO] 2020―May―12 The Post-COVID-19 Functional Status (PCFS) Scale: a tool to measure functional status over time after COVID-19 F.A. Klok, G.J.A.M. Boon, S. Barco, M. Endres, J.J.M. Geelhoed, S. Knauss, et al. (+4)
312 [GO] 2020―May―12 Could the smoking gun in the fight against Covid-19 be the (rh) ACE2? Dhamend Lutchman
313 [GO] 2020―May―12 Easier access to mechanical ventilation worldwide: an urgent need for low income countries, especially in face of the growing COVID-19 crisis Claude Guérin, Patrick Lévy
314 [GO] 2020―May―12 An Italian sacrifice to COVID-19 epidemic Stefano Nava, Roberto Tonelli, Enrico Clini
315 [GO] 2020―May―12 Risk Factors for Viral RNA Shedding in COVID-19 Patients Yu Fu, Ping Han, Rui Zhu, Tao Bai, Jianhua Yi, Xi Zhao, et al. (+9)
316 [GO] 2020―May―12 Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients Hai-qiong Yu, Bao-qing Sun, Zhang-fu Fang, Jin-cun Zhao, Xiao-yu Liu, Yi-min Li, et al. (+17)
317 [GO] 2020―May―12 Pulmonary embolism in patients with Covid-19 pneumonia Florian Bompard, Hippolyte Monnier, Ines Saab, Mickael Tordjman, Hendy Abdoul, Laure Fournier, et al. (+4)
318 [GO] 2020―May―12 To compare the incomparable: COVID-19 pneumonia and high altitude disease Giacomo Strapazzon, Matthias P Hilty, Pierre Bouzat, Lorenza Pratali, Hermann Brugger, Simon Rauch
319 [GO] 2020―May―12 Will Children Reveal their Secret? The Coronavirus Dilemma George James Porter
320 [GO] 2020―May―12 Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it? Maarten Criel, Maarten falter, Jasmien Jaeken, Margaretha Van Kerrebroeck, Isabelle Lefere, Liesbeth Meylaerts, et al. (+5)
321 [GO] 2020―May―07 Abnormal pulmonary function in COVID-19 patients at time of hospital discharge Xiaoneng Mo, Wenhua Jian, Zhuquan Su, Mu Chen, Hui Peng, Ping Peng, et al. (+4)
322 [GO] 2020―May―05 Sleep apnoea management in Europe during the COVID-19 pandemic: data from the European Sleep Apnoea Database (ESADA) Ludger Grote, Walter T. McNicholas, Jan Hedner
323 [GO] 2020―May―05 Reply to: “Current Smoking is Not Associated with COVID-19 Janice M. Leung, Chen Xi Yang, Don D. Sin
324 [GO] 2020―May―05 Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China Xiaorong Wang, Qiong Zhou, Yukun He, Lingbo Liu, Xinqian Ma, Xiaoshan Wei, et al. (+21)
325 [GO] 2020―Apr―29 Current Smoking is Not Associated with COVID-19 Marco Rossato, Lucia Russo, Sara Mazzocut, Angelo Di Vincenzo, Paola Fioretto, Roberto Vettor
326 [GO] 2020―Apr―29 COVID-19 and Nicotine as a Mediator of ACE-2 Janice M. Leung, Chen Xi Yang, Don D. Sin
327 [GO] 2020―Apr―29 Universal use of face masks for success against COVID-19: evidence and implications for prevention policies Susanna Esposito, Nicola Principi, Chi Chi Leung, Giovanni Battista Migliori
328 [GO] 2020―Apr―29 Putative contributions of circadian clock and sleep in the context of SARS-CoV-2 infection Miguel Meira e Cruz, Masaaki Miyazawa, David Gozal
329 [GO] 2020―Apr―27 Cardiovascular comorbidity and its impact on patients with Covid-19 Wei-jie Guan, Wen-hua Liang, Jian-xing He, Nan-shan Zhong
330 [GO] 2020―Apr―27 COVID-19 and Smoking. Is Nicotine the Hidden Link? Patrizia Russo, Stefano Bonassi, Robertina Giacconi, Marco Malavolta, Carlo Tomino, Fabrizio Maggi
331 [GO] 2020―Apr―27 Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective David M. G. Halpin, Dave Singh, Ruth M. Hadfield
332 [GO] 2020―Apr―27 Clinical phenotypes of SARS-CoV-2: Implications for clinicians and researchers Jordi Rello, Enrico Storti, Mirko Belliato, Ricardo Serrano
333 [GO] 2020―Apr―21 Association Between Ages and Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Yang Liu, Bei Mao, Shuo Liang, Jia-wei Yang, Hai-wen Lu, Yan-hua Chai, et al. (+16)
334 [GO] 2020―Apr―21 Short-term Outcomes of Coronavirus Disease 2019 and Risk Factors for Progression Li Long, Xiansheng Zeng, Xu Zhang, Wei Xiao, E. Guo, Wenzhi Zhan, et al. (+9)
335 [GO] 2020―Apr―16 High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion Jie Li, James B. Fink, Stephan Ehrmann
336 [GO] 2020―Apr―09 Managing the supportive care needs of those affected by COVID-19 S. Bajwah, A. Wilcock, R. Towers, M. Costantini, C. Bausewein, S. T. Simon, et al. (+9)
337 [GO] 2020―Apr―09 ACE-2 Expression in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19 Janice M. Leung, Chen X. Yang, Anthony Tam, Tawimas Shaipanich, Tillie-Louise Hackett, Gurpreet K. Singhera, et al. (+2)
338 [GO] 2020―Apr―09 Pathogenesis of COVID-19 from a cell biology perspective Robert J. Mason
339 [GO] 2020―Apr―09 Predictors of Mortality for Patients with COVID-19 Pneumonia Caused by SARS-CoV-2: A Prospective Cohort Study Rong-Hui Du, Li-Rong Liang, Cheng-Qing Yang, Wen Wang, Tan-Ze Cao, Ming Li, et al. (+8)
340 [GO] 2020―Apr―09 No Association of COVID-19 transmission with temperature or UV radiation in Chinese cities Ye Yao, Jinhua Pan, Zhixi Liu, Xia Meng, Weidong Wang, Haidong Kan, Weibing Wang
341 [GO] 2020―Apr―09 Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (non-epicenter): A Nationwide Analysis of China Wen-hua Liang, Wei-jie Guan, Cai-chen Li, Yi-min Li, Heng-rui Liang, Yi Zhao, et al. (+44)
342 [GO] 2020―Apr―09 Novel Coronavirus Infection in Newborn Babies Under 28 Days in China Zhi-Jiang Zhang, Xue-Jie Yu, Tao Fu, Yu Liu, Yan Jiang, Bing Xiang Yang, Yongyi Bi
343 [GO] 2020―Apr―07 Current Status of Cell-Based Therapies for Respiratory Virus Infections: Applicability to COVID-19 Maroun Khoury, Jimena Cuenca, Fernanda F. Cruz, Fernando E. Figueroa, Patricia R. M. Rocco, Daniel J. Weiss
344 [GO] 2020―Apr―07 Early consensus management for non-ICU ARF SARS-CoV-2 emergency in Italy: from ward to trenches Michele Vitacca, Stefano Nava, Pierachille Santus, Sergio Harari
345 [GO] 2020―Apr―02 Celebrating TB day at the time of COVID-19 Riccardo Alagna, Giorgio Besozzi, Luigi Ruffo Codecasa, Andrea Gori, Giovanni Battista Migliori, Mario Raviglione, Daniela Maria Cirillo
346 [GO] 2020―Apr―02 Will children reveal their secret? The coronavirus dilemma Luca Cristiani, Enrica Mancino, Luigi Matera, Raffaella Nenna, Alessandra Pierangeli, Carolina Scagnolari, Fabio Midulla
347 [GO] 2020―Mar―26 Urgent need of a management plan for survivors of COVID-19 Bartolome Celli, Leonardo M. Fabbri
348 [GO] 2020―Mar―26 Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis Wei-jie Guan, Wen-hua Liang, Yi Zhao, Heng-rui Liang, Zi-sheng Chen, Yi-min Li, et al. (+41)
349 [GO] 2020―Mar―26 Clinical and CT features of early-stage patients with COVID-19: a retrospective analysis of imported cases in Shanghai, China Shuyi Yang, Yuxin Shi, Hongzhou Lu, Jianqing Xu, Feng Li, Zhiping Qian, et al. (+7)
350 [GO] 2020―Mar―26 Strategies for the prevention and management of coronavirus disease 2019 Wei-jie Guan, Rong-chang Chen, Nan-shan Zhong
351 [GO] 2020―Mar―20 More awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from China Lili Guan, Luqian Zhou, Jinnong Zhang, Wei Peng, Rongchang Chen
352 [GO] 2020―Mar―05 The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, China Lei Wang, Yong-hua Gao, Li-Li lou, Guo-Jun Zhang
353 [GO] 2020―Mar―05 Epidemiological characteristics of 2019-ncoV infections in Shaanxi, China by February 8, 2020 Yang Yao, Yao Tian, Jing Zhou, Xuan Ma, Min Yang, ShengYu Wang
 [1] 

353 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.058 sec